Bli medlem
Bli medlem

Du är här


Navamedic ASA: World premiere of SIPPI® wireless capabilities

Oslo, 23. February 2016 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, will for the first time present wireless communication capabilities of the urine volume measurement system SIPPI® at the Symposium on Intensive Medicine and Intensive Care in Bremen from 24 to 26 February 2016.

More than 4,600 participants are expected to attend the event, which is the largest interdisciplinary and independent congress on intensive medicine in Germany. As last year,the SIPPI® system will be represented by pfm medical with its own stand (Hall 4, P14) on the site.

In addition to the world premiere of SIPPI® wireless transfer of data, advantages like fully automated volume measurement of hourly diuresis, biofilm control, and the biofilminhibiting technology of Sippcoat® will be presented.

For further information, please contact:
Tom Rönnlund, CEO, Navamedic. Telephone +46 727 320 321.

Navamedic ASA is a Norwegian medtech and pharmaceutical products company, delivering products to patients, hospitals and pharmacies in the Nordic and Benelux markets. The Group's Medtech business has
developed and is currently introducing the next generation of digital urine meter Sippi®. Navamedic's Pharma and Healthcare business is a distributorof products supplied by a number of pharmaceutical manufacturers. Navamedic is listed on the Oslo Stock Exchange (ticker: NAVA).


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Navamedic ASA via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.